The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme-Reference-Cited by-同舟云学术

The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme

Published:2016-02-01 Issue:2 Volume:15 Page:131-139
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Carnovale Carla¹,Gentili Marta¹,Fortino Ida²,Merlino Luca²,Clementi Emilio³⁴,Radice Sonia¹,on behalf the ViGer Group

Affiliation:

1. Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital “Luigi Sacco”, Università di Milano, Milan, Italy

2. Regional Health Ministry, Milan, Lombardy Region, Italy

3. Scientific Institute, IRCCS E. Medea, Bosisio Parini, Lecco, Italy

4. Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, Consiglio Nazionale delle Ricerche Institute of Neuroscience, University Hospital “Luigi Sacco”, Milan, Italy

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14740338.2016.1131816

Reference46 articles.

1. Papers of special note have been highlighted as:

2. • of interest

3. •• of considerable interest

4. Predicting and Preventing Adverse Drug Reactions in the Very Old

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Hemp Seed Oil on Drug-Drug Interactions: A Comprehensive Review of Potential Mechanisms and Clinical Implications;2023-09-25

2. Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system;Frontiers in Pharmacology;2023-07-10

3. Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System;Expert Opinion on Drug Safety;2023-06-12

4. Safety of antithrombotic therapy in elderly patients: analysis of the Russian Pharmacovigilance Database;Hirurg (Surgeon);2022-06-14

5. Patient harm from cardiovascular medications;Therapeutic Advances in Drug Safety;2021-01